Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $9.18M by Medicaid between Jan 2018 and Dec 2024, across 192 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
SAN JOSE, CA 95119
SAN JOSE, CA 95119
33aNPI1063582989assigned 11/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.18M
24GClaims691,305
24DCodes billed192
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#188 of 410
Median peer was paid$6.90M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,256 | $284K | |
| 2019 | 72,556 | $338K | |
| 2020 | 68,552 | $319K | |
| 2021 | 95,225 | $451K | |
| 2022 | 125,866 | $609K | |
| 2023 | 140,815 | $565K | |
| 2024incomplete | 141,035 | $6.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 11,674 | 10,909 | $1.86M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 11,367 | 10,888 | $1.07M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.4% | 5,914 | 5,752 | $859K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 3,692 | 3,487 | $610K |
| 0450 | Emergency room services | 6.3% | 29,497 | 26,057 | $581K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.5% | 4,826 | 4,746 | $501K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.3% | 12,377 | 11,833 | $482K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4.1% | 8,146 | 7,918 | $373K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 6,580 | 6,442 | $186K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 5,132 | 4,967 | $182K |
| 99199 | Unlisted special service, procedure or report | 1.6% | 3,166 | 2,782 | $146K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.2% | 3,917 | 3,867 | $113K |
180 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 1,974 | $109K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 7,482 | $94K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,218 | $91K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14,454 | $84K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,449 | $82K |
| 76830 | Ultrasound, transvaginal | <1% | 2,046 | $81K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,027 | $81K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,438 | $69K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 37,896 | $63K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 488 | $53K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 6,370 | $50K |
| 73630 | <1% | 2,236 | $47K | |
| 80051 | <1% | 26,893 | $44K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,720 | $41K |
| 73610 | <1% | 1,906 | $40K | |
| 72100 | <1% | 1,404 | $36K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 33,103 | $32K |
| 73130 | <1% | 1,454 | $31K | |
| 82565 | <1% | 30,248 | $31K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,324 | $30K |
| 73560 | <1% | 1,785 | $30K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,027 | $30K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 124 | $29K |
| 73030 | <1% | 1,496 | $27K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 532 | $26K |
| 84702 | <1% | 10,052 | $26K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 397 | $26K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,193 | $25K |
| 73110 | <1% | 1,129 | $24K | |
| 73564 | <1% | 400 | $24K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 283 | $23K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,632 | $23K |
| G0378 | Hospital observation service, per hour | <1% | 1,981 | $23K |
| 84520 | <1% | 26,627 | $22K | |
| 83880 | <1% | 4,585 | $21K | |
| 82947 | <1% | 26,699 | $21K | |
| 93971 | <1% | 605 | $21K | |
| 84484 | <1% | 9,151 | $21K | |
| 83690 | <1% | 12,960 | $20K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 176 | $20K |
| 74018 | <1% | 823 | $20K | |
| 82247 | <1% | 17,519 | $19K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,101 | $19K |
| 84460 | <1% | 17,002 | $19K | |
| 87631 | <1% | 898 | $18K | |
| 0270 | <1% | 8,636 | $17K | |
| 84450 | <1% | 15,844 | $17K | |
| 70486 | <1% | 237 | $17K | |
| 84075 | <1% | 14,401 | $15K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,351 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,351 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,221 | $15K |
| 72040 | <1% | 532 | $15K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 11,743 | $15K |
| 73140 | <1% | 670 | $13K | |
| 81001 | <1% | 18,451 | $13K | |
| 86900 | <1% | 2,136 | $12K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,302 | $12K |
| 73080 | <1% | 412 | $11K | |
| 73502 | <1% | 366 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 270 | $10K |
| 87040 | <1% | 2,675 | $9K | |
| 93976 | <1% | 374 | $9K | |
| 71250 | <1% | 212 | $9K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 324 | $9K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,852 | $7K |
| 83605 | <1% | 3,104 | $7K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,183 | $7K |
| 80306 | <1% | 1,792 | $7K | |
| 83735 | <1% | 6,035 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,614 | $7K |
| 86850 | <1% | 1,685 | $6K | |
| 87088 | <1% | 4,695 | $6K | |
| 85610 | <1% | 9,082 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 93 | $6K |
| 82077 | <1% | 1,649 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,818 | $6K |
| 81003 | <1% | 11,182 | $5K | |
| Z7502 | <1% | 433 | $5K | |
| J3490 | Unclassified drugs | <1% | 3,167 | $5K |
| 86901 | <1% | 2,136 | $5K | |
| 76536 | <1% | 214 | $5K | |
| 0250 | <1% | 6,765 | $4K | |
| 76770 | <1% | 160 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 146 | $4K |
| 85652 | <1% | 6,504 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,028 | $4K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,192 | $3K |
| 72141 | <1% | 24 | $3K | |
| 82248 | <1% | 1,634 | $3K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 243 | $3K |
| 76857 | <1% | 51 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,749 | $3K |
| 82962 | <1% | 4,105 | $3K | |
| 85379 | <1% | 966 | $2K | |
| 85027 | <1% | 2,201 | $2K | |
| 80179 | <1% | 666 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,758 | $2K |
| 86140 | <1% | 1,283 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,841 | $2K |
| 86923 | <1% | 13 | $2K | |
| 84100 | <1% | 2,410 | $2K | |
| 76376 | <1% | 121 | $2K | |
| 73590 | <1% | 113 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 496 | $2K |
| 73562 | <1% | 28 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 12 | $2K |
| 72131 | <1% | 15 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,545 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 403 | $1K |
| 0637 | <1% | 35,918 | $1K | |
| 82570 | <1% | 291 | $1K | |
| 71101 | <1% | 37 | $1K | |
| 82310 | <1% | 821 | $1K | |
| 84132 | <1% | 1,027 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 271 | $1K |
| 82040 | <1% | 653 | $1K | |
| 85730 | <1% | 766 | $1K | |
| 72070 | <1% | 12 | $916.12 | |
| 59025 | Fetal non-stress test | <1% | 141 | $908.27 |
| 84295 | <1% | 364 | $883.12 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 748 | $878.48 |
| 87324 | <1% | 152 | $877.70 | |
| 87449 | <1% | 158 | $869.12 | |
| 84156 | <1% | 283 | $846.52 | |
| 90715 | <1% | 54 | $801.87 | |
| 0710 | <1% | 1,461 | $729.10 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 408 | $502.24 |
| J1815 | Injection, insulin, per 5 units | <1% | 975 | $453.06 |
| 0370 | <1% | 1,224 | $437.25 | |
| 85378 | <1% | 290 | $433.99 | |
| 85007 | <1% | 753 | $425.01 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 307 | $420.51 |
| 73090 | <1% | 119 | $391.46 | |
| 82550 | <1% | 230 | $337.08 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 597 | $265.16 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 489 | $263.60 |
| 93970 | <1% | 13 | $220.37 | |
| 73620 | <1% | 73 | $214.78 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 79 | $211.44 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,013 | $202.59 |
| 82803 | <1% | 28 | $197.46 | |
| 82272 | <1% | 29 | $185.00 | |
| 73600 | <1% | 57 | $172.55 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 25 | $141.60 |
| 76882 | <1% | 33 | $133.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 354 | $104.27 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 180 | $102.39 |
| 80069 | <1% | 45 | $84.08 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 38 | $77.42 |
| 12001 | <1% | 44 | $77.21 | |
| 83615 | <1% | 64 | $71.82 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 39 | $71.02 |
| 96376 | <1% | 836 | $70.47 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 54 | $50.71 |
| 76870 | <1% | 12 | $47.16 | |
| 82728 | <1% | 15 | $43.45 | |
| 87070 | <1% | 14 | $40.34 | |
| J8501 | Aprepitant, oral, 5 mg | <1% | 25 | $40.30 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 40 | $35.01 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 12 | $23.37 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 14 | $18.46 |
| 73660 | <1% | 13 | $17.22 | |
| 73120 | <1% | 13 | $15.63 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $13.38 |
| 29125 | <1% | 12 | $10.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 106 | $4.95 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 55 | $3.88 |
| 85008 | <1% | 349 | $3.35 | |
| 0272 | 0% | 38 | $0.00 | |
| 80325 | 0% | 25 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 22 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 51 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 12 | $0.00 |
| 76942 | 0% | 12 | $0.00 | |
| 80329 | 0% | 23 | $0.00 | |
| 80320 | 0% | 235 | $0.00 | |
| 0258 | 0% | 294 | $0.00 | |
| 87081 | 0% | 13 | $0.00 | |
| 80349 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAVEZ, IRENE (SENIOR VICE PRESIDENT, AREA MANAGER)